Korea University Anam Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

CYP2D6 Genotype on the Clinical Effect of Tamoxifen

Conditions: Breast Neoplasms
Tamoxifen
Genotype
CYP2D6

Interventions: Drug: Tamoxifen

First Posted Date: 2009-09-09

Last Posted Date: 2009-09-09

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 922

Registration Number: NCT00973037

Locations: 🇰🇷
Korea University Anam Hopital, Seoul, Korea, Republic of

CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)

Conditions: Arthritis
Breast Neoplasms
Arthralgia
Genetic Polymorphism

Interventions: Drug: Aromatase Inhibitor(Femara or Arimidex)

First Posted Date: 2009-09-09

Last Posted Date: 2009-09-09

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 100

Registration Number: NCT00973505

Locations: 🇰🇷
Korea University Anam Hopital, Seoul, Korea, Republic of

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

Phase 4

Completed

Conditions: Diabetes
Hypertension
Coronary Artery Disease

Interventions: Drug: telmisartan
Drug: valsartan

First Posted Date: 2008-01-24

Last Posted Date: 2015-09-03

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 72

Registration Number: NCT00599885

Locations: 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Phase 4

Conditions: Diabetes Mellitus, Type 2
Metabolic Syndrome X

Interventions: Drug: Placebo
Drug: cilostazol

First Posted Date: 2007-12-14

Last Posted Date: 2007-12-14

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 48

Registration Number: NCT00573950

Locations: 🇰🇷
Korea Univerisity Anam Hospital, Seoul, Korea, Republic of

Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial Infarction

Phase 4

Completed

Conditions: Acute Myocardial Infarction

First Posted Date: 2007-09-28

Last Posted Date: 2012-04-09

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 100

Registration Number: NCT00536887

Locations: 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers

Phase 4

Completed

Conditions: Diabetes Mellitus
Coronary Artery Stenosis

Interventions: Drug: Pioglitazone
Drug: Placebo

First Posted Date: 2007-06-29

Last Posted Date: 2016-02-25

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 240

Registration Number: NCT00494559

Locations: 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

Phase 2

Completed

Conditions: Neoplasm Metastasis
Pancreatic Neoplasm

Interventions: Drug: gemcitabine, TS-1

First Posted Date: 2007-02-19

Last Posted Date: 2007-11-01

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 38

Registration Number: NCT00436423

Locations: 🇰🇷
YeulHong Kim, Seoul, Korea, Republic of

The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome

Phase 4

Completed

Conditions: Metabolic Syndrome

First Posted Date: 2006-04-14

Last Posted Date: 2011-07-01

Lead Sponsor: Korea University Anam Hospital

Target Recruit Count: 40

Registration Number: NCT00314561

Locations: 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy